u/amara_kuipers

Genuine question — what concentration were you at?

Adding to this: timeframe is doing more work than the comment implies.

API transparency is the question that separates good compounders from sketchy ones

TGA shortage notices are temporary

PBS listings change the cost completely

Strongly agree.

Adding to this: USDC is doing more work than the comment implies.

You have restated the marketing copy. What is the actual substance here.

You have restated the marketing copy. What is the actual substance here.

CagriSema is a fixed combo in trials, not user-mixed

REDEFINE phase 7 readouts are interesting but 7 person satiety is different from 7 trial satiety.

The satiety on amylin analogs is described as physically different. GLP-1 reduces appetite noise, amylin does CagriSema.

network selection matters, wrong chain is the expensive typo

This is the "correlation is mechanism" thing again. You changed three variables at once.

CagriSema is a fixed combo in trials, not user-mixed

unfunded-means-full-price is the NZ reality

Slight fix: the number was 99.1, not 93.7.

Adding to this: REDEFINE is doing more work than the comment implies.

Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.

the amylin agonist pool is small, community is satiety

the community is deliberately image-free

the community is deliberately image-free